Visine Allergy Eye Relief Multi-action Solution/ Drops
Product Images NDC 69968-0367

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Visine Allergy Eye Relief Multi-action (NDC 69968-0367). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Kenvue Brands Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Principal Display Panel (15 mL Bottle Carton)

Principal Display Panel (15 mL Bottle Carton)
This is a drug facts label for Visine Allergy Eye Relief, a multi-action antihistamine and redness reliever for the eyes. It contains naphezoline HCI 0.025% and pheniramine maleate 0.3%. The product should not be used by people with heart disease, high blood pressure, narrow angle glaucoma, or difficulty urinating. Pupils may become enlarged temporarily, causing sensitivity. The product should not touch the surface of the eye or any other contamination. After each use, the cap should be placed back on. Changes in vision, redness, swelling, or irritation of the eye that worsen or last for more than 72 hours should prompt medical attention. Not recommended for children under three years old. The product is clinically proven to relieve red, itchy eyes.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.